Advertisement
PolyTouch has developed PatchAssist, an FDA cleared laparoscopic surgicalinstrument that enables accurate and rapid delivery and placement of softtissue prosthetics for a variety of procedures, including laparoscopicventral hernia repair (LVHR). PatchAssistTM is a stand-alone surgical devicethat is compatible with all currently commercialized soft tissue prosthetics.PatchAssist enables surgeons to rapidly deliver and position soft tissueprosthetics over the defect potentially reducing operation time by 30% - 50%.
Advertisement
Dr. Robert D. Fanelli is the president of Surgical Specialists of WesternNew England P.C., and has extensive experience in minimally invasive surgery,gastrointestinal surgery, and advanced gastrointestinal andpancreaticobiliary endoscopy. Dr. Fanelli is an editorial review board memberfor http://www.minimallyinvasiveprocedures.com, a community-based video wiki;and a peer reviewer for the Annals of Surgery, Journal of the AmericanCollege of Surgeons, and Surgical Endoscopy. He has presented and publishedmore than 200 articles in peer-reviewed medical literature and has receivednumerous awards and appears in the Guide to America's Top Surgeons -Excellence in Gastrointestinal Surgery, Minimally Invasive Surgery, andGastrointestinal & Biliary Endoscopy; and Who's Who in America.
Dr. Fanelli completed medical school at the Medical College ofPennsylvania; residency programs at the Stamford Hospital General SurgeryResidency and Michigan State University; and a fellowship at Mount SinaiMedical Center. He has developed a number of successful products, and hasassisted with countless others.
"Dr. Fanelli has outstanding abilities for assisting in medical productdevelopments. I am delighted and honored to have Dr. Fanelli join our U.S.Medical Advisory Board," remarked Ofek Levin, Founder and CEO of PolyTouchMedical.
Dr. Fanelli commented, "PatchAssist has the potential to revolutionizelaparoscopic ventral hernia repair. By streamlining the tedious process ofintroducing, unfurling, and positioning the mesh, this unique product enablesrapid deployment and accurate placement of even the largest pieces of mesh,including even lightweight synthetics and floppy biologics. Based on my earlyexperience with this device, PatchAssist will save substantial time in theoperating room and therefore is poised to help trim the overall costs ofdelivering care for patients with ventral hernias."
As previously reported, PolyTouch announced on June 21, that it hasreceived FDA clearance to commercialize PatchAssist(TM)
PolyTouch announced on April 26th, the appointment of Karl A. LeBlanc,MD, MBA, FACS, as Medical Advisor.
PolyTouch announced April 12th, the appointment of Morris E. FranklinJr., MD, FACS, as Medical Advisor.
On January 25th, PolyTouch announced the appointment of William Edelmanas Chairman of the Board.
About PolyTouch Medical Ltd.
PolyTouch Medical was founded in March 2009 and is located in the MisgavVenture Accelerator, Israel. PolyTouch is a portfolio company of TheTrendlines Group's (http://www.trendlines.com) Misgav Venture Accelerator(http://www.misgav-venture.com). PatchAssist(TM) is an innovativelaparoscopic surgical instrument that enables accurate and rapid delivery andplacement of soft tissue prosthetics for a variety of procedures, includinglaparoscopic ventral hernia repair (LVHR) potentially reducing procedure timeby 30%-50%. PolyTouch plans to introduce the PatchAssist(TM) device into theU.S. market in the beginning of 2011.
SOURCE PolyTouch Medical Ltd.
